These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 2128881)

  • 1. Induction of ovulation with pulsatile subcutaneous administration of human menopausal gonadotropin in patients with polycystic ovary syndrome.
    Nakamura Y; Yamada H; Yoshida K; Manno T; Ubukata Y; Suzuki M; Yoshimura Y
    Horm Res; 1990; 33 Suppl 2():43-8. PubMed ID: 2128881
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A study on follicle stimulation and ovulation induction in polycystic ovary syndrome (PCOS).
    Ito T; Michioka T; Kobayashi M; Narimatsu A; Yamashita S; Matsuzaki H; Kuramoto T; Numa F; Yakabe A
    Horm Res; 1990; 33 Suppl 2():32-4. PubMed ID: 2128879
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of polycystic ovarian disease by inducing ovulation with pulsatile subcutaneous administration of human menopausal gonadotrophin associated with luteinizing hormone-releasing hormone analogue.
    Nakamura Y; Yoshimura Y; Tamaoka Y; Ubukata Y; Yoshida K; Yamada H; Iizuka R; Suzuki M
    Clin Endocrinol (Oxf); 1988 Oct; 29(4):395-402. PubMed ID: 3150824
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Ovulation induction with a combination of LHRH analogue and hMG pulsatile subcutaneous administration in PCO patients].
    Nakamura Y; Yoshimura Y; Tamaoka Y; Yamada H; Iizuka R; Suzuki M
    Nihon Sanka Fujinka Gakkai Zasshi; 1987 Dec; 39(12):2157-64. PubMed ID: 3123581
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Native gonadotropin-releasing hormone for triggering follicular maturation in polycystic ovary syndrome patients undergoing human menopausal gonadotropin ovulation induction.
    Blumenfeld Z; Lang N; Amit A; Kahana L; Yoffe N
    Fertil Steril; 1994 Sep; 62(3):456-60. PubMed ID: 8062938
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Ovulation induction with pulsatile gonadotropin-releasing hormone and continuous human menopausal gonadotropin in polycystic ovarian disease].
    Kuroda G
    Nihon Naibunpi Gakkai Zasshi; 1987 Mar; 63(3):247-59. PubMed ID: 3111899
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical experience in the induction of ovulation and pregnancy with pulsatile subcutaneous administration of human menopausal gonadotropin: a low incidence of multiple pregnancy.
    Nakamura Y; Yoshimura Y; Yamada H; Ubukata Y; Yoshida K; Tamaoka Y; Suzuki M
    Fertil Steril; 1989 Mar; 51(3):423-9. PubMed ID: 2493402
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of LHRH agonists in the treatment of anovulation in women with polycystic ovary syndrome.
    Franks S; Sagle M; Mason HD; Kiddy D
    Horm Res; 1987; 28(2-4):164-8. PubMed ID: 3136067
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Successful induction of ovulation and conception with combined gonadotropin-releasing hormone agonist plus highly purified follicle-stimulating hormone in patients with polycystic ovarian disease.
    Lanzone A; Fulghesu AM; Spina MA; Apa R; Menini E; Caruso A; Mancuso S
    J Clin Endocrinol Metab; 1987 Dec; 65(6):1253-8. PubMed ID: 3119655
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Specific factors predict the response to pulsatile gonadotropin-releasing hormone therapy in polycystic ovarian syndrome.
    Gill S; Taylor AE; Martin KA; Welt CK; Adams JM; Hall JE
    J Clin Endocrinol Metab; 2001 Jun; 86(6):2428-36. PubMed ID: 11397835
    [TBL] [Abstract][Full Text] [Related]  

  • 11. GnRH agonist administration in polycystic ovary syndrome.
    Buckler HM; Phillips SE; Kovacs GT; Burger HG; Healy DL
    Clin Endocrinol (Oxf); 1989 Aug; 31(2):151-65. PubMed ID: 2514053
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of gonadotropin-releasing hormone agonists and antagonists in assisted reproduction cycles of polycystic ovarian syndrome patients.
    Hosseini MA; Aleyasin A; Saeedi H; Mahdavi A
    J Obstet Gynaecol Res; 2010 Jun; 36(3):605-10. PubMed ID: 20598044
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clomiphene citrate-resistant polycystic ovary syndrome. Preventing multifollicular development.
    Ergür AR; Yergök YZ; Ertekin A; Küçük T; Müngen E; Tütüncü L
    J Reprod Med; 1998 Mar; 43(3):185-90. PubMed ID: 9564642
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stimulation with human menopausal gonadotropin versus follicle-stimulating hormone after pituitary suppression in polycystic ovarian syndrome.
    Tanbo T; Dale PO; Kjekshus E; Haug E; Abyholm T
    Fertil Steril; 1990 May; 53(5):798-803. PubMed ID: 2110071
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gonadotropin-releasing hormone (GnRH) analog suppression renders polycystic ovarian disease patients more susceptible to ovulation induction with pulsatile GnRH.
    Filicori M; Campaniello E; Michelacci L; Pareschi A; Ferrari P; Bolelli G; Flamigni C
    J Clin Endocrinol Metab; 1988 Feb; 66(2):327-33. PubMed ID: 3123511
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of clomiphene citrate-resistant polycystic ovarian syndrome with pure follicle-stimulating hormone or human menopausal gonadotropin.
    McFaul PB; Traub AI; Thompson W
    Fertil Steril; 1990 May; 53(5):792-7. PubMed ID: 2110070
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pulsatile luteinising hormone releasing hormone for ovulation induction in subfertility associated with polycystic ovary syndrome.
    Bayram N; van Wely M; Vandekerckhove P; Lilford R; van Der Veen F
    Cochrane Database Syst Rev; 2000; (2):CD000412. PubMed ID: 10796718
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Initial experiences with subcutaneous pulsatile human menopausal gonadotropin administration: successful induction of ovulation in patients with polycystic ovarian disease.
    Rossmanith WG; Sterzik K; Wolf AS
    Int J Fertil; 1987; 32(6):460-6. PubMed ID: 2891635
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of combined exogenous gonadotropins and pulsatile gonadotropin-releasing hormone in patients with polycystic ovarian disease: a new approach to induction of ovulation.
    Venturini PL; Remorgida V; Anserini P; De Cecco L
    Gynecol Endocrinol; 1988 Sep; 2(3):205-13. PubMed ID: 3147583
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparative, randomized study of low-dose human menopausal gonadotropin and follicle-stimulating hormone in women with polycystic ovarian syndrome.
    Sagle MA; Hamilton-Fairley D; Kiddy DS; Franks S
    Fertil Steril; 1991 Jan; 55(1):56-60. PubMed ID: 1898891
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.